Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Shenzhen King Explorer Science and Technology Corporation (002917.SZ)
Shenzhen, CN
Shenzhen King Explorer Science and Technology Corporation specializes in the creation, engineering, production, and distribution of sophisticated intelligent equipment systems. These systems are supplied to enterprises involved in civil explosive manufacturing and blasting services, both within the People's Republic of China and across international borders. Its comprehensive product portfolio includes industrial production lines for explosives and detonators, mobile and stationary bulk emulsion modules, and specialized bulk trucks designed for emulsion, ANFO, and heavy ANFO products. Additionally, the company provides portable underground charging units and dedicated underground chargers. Further offerings encompass robotic packaging lines, precise track and trace systems for explosive materials and detonators, and the advanced JWL-RMA information and equipment management systems. King Explorer also furnishes essential chemical components such as emulsifier concentrates for bulk and packaged emulsion, along with fuel phases crucial for packaged emulsion explosives. Complementing its product range, the company extends expert technical consulting services. Established in 1994, the company's main operational base is located in Shenzhen, PRC.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.85% | -4.71% | +3.99% | -5.84% | +1.04% | +1.27% | +0.37% | +24.66% | +61.12% | +94.13% | +94.13% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-06 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+8.4% ★ Q1'26: +0.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+41.7% ★ Q1'26: +10.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+15.8% ★ Q1'26: -5.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+14.8% ★ Q1'26: +14.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+13.6% ★ Q1'26: +8.7% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.3% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.25× ★ Q1'26: 2.03× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
853.00M
est.
|
815.11M
est: 1.60B (-49.1%)
|
1.19B
est: 1.63B (-26.9%)
|
1.51B
est: 1.63B (-7.6%)
|
1.63B
est: 2.29B (-28.7%)
|
1.77B
est: 3.13B (-43.4%)
|
3.01B
3.01B – 3.01B
-3.9% YoY
|
| EBITDA |
117.41M
est.
|
90.38M
est: 220.51M (-59.0%)
|
88.01M
est: 224.64M (-60.8%)
|
222.64M
est: 224.64M (-0.9%)
|
265.04M
est: 702.70M (-62.3%)
|
344.91M
est: 959.84M (-64.1%)
|
922.10M
922.10M – 922.10M
-3.9% YoY
|
| EBIT |
72.52M
est.
|
51.79M
est: 136.21M (-62.0%)
|
12.75M
est: 138.76M (-90.8%)
|
146.82M
est: 138.76M (+5.8%)
|
192.83M
est: 612.51M (-68.5%)
|
261.11M
est: 836.65M (-68.8%)
|
803.75M
803.75M – 803.75M
-3.9% YoY
|
| Net Income |
63.46M
est.
|
39.90M
est: 96.05M (-58.5%)
|
25.26M
est: 116.63M (-78.3%)
|
101.66M
est: 116.63M (-12.8%)
|
124.08M
est: 198.40M (-37.5%)
|
174.57M
est: 297.60M (-41.3%)
|
307.87M
307.87M – 307.87M
+3.4% YoY
|
| SGA |
62.38M
est.
|
112.48M
est: 117.15M (-4.0%)
|
206.86M
est: 119.35M (+73.3%)
|
246.95M
est: 119.35M (+106.9%)
|
279.67M
est: 328.86M (-15.0%)
|
126.45M
est: 449.21M (-71.9%)
|
431.55M
431.55M – 431.55M
-3.9% YoY
|
| EPS |
0.19
est.
|
0.15
est: 0.28 (-46.4%)
|
0.07
est: 0.34 (-78.2%)
|
0.29
est: 0.34 (-14.7%)
|
0.36
est: 0.58 (-37.9%)
|
0.51
est: 0.87 (-41.4%)
|
0.90
0.90 – 0.90
+3.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Caixia Tang | Accounting Supervisor | — | — |
| Gang Ming | GM & Chairman | — | male |
| Ji Hong Cui | Chief Financial Officer | — | female |
| Jingang Liang | Deputy GM & Non-Independent Director | — | male |
| Xiaoxi Zhou | Deputy General Manager | — | male |
| Yiling Zhou | Deputy GM, Board Secretary & Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002917.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
